Clinical trial · Interventional
My Grief - an App for Parents With Prolonged Grief After Losing a Child to Cancer
My Grief - Development and Evaluation of an App for Parents With Prolonged Grief Disorder After Losing a Child to Cancer: a Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Bereaved parents are at increased risk of developing mental and physical health problems and bereavement is even associated with an increased risk of mortality, especially in mothers. Prolonged grief disorder (PGD) are persistent and intensive grief reactions which can persist for years. It is characterized by an intense and lasting yearning for the deceased, intense emotional pain, such as difficulty accepting the loss and an inability to experience positive mood. Parents are among the most vulnerable to develop PGD. The goal is to increase the accessibility to evidence-based and cost-effective interventions for parents of children who have died of cancer, and thus facilitate the grieving process and decrease the risk for parents to develop long-term distress. Specific aims are: * To evaluate the acceptability and feasibility of a mobile app, "My Grief ", a self-help app for prolonged grief, in parents who lost a child to cancer. * To evaluate possible beneficial effects of the mobile app on parents' mental health.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prolonged Grief Disorder | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| My Grief | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Participants will complete a web based pre-assessment and then given access to the app "My Grief" for three months followed by a web based post-assessment and an interview via telephone regarding their experiences of using the app, and follow-up questionnaires.
- interventionNames
- Other: My Grief
- type
- NO_INTERVENTION
- label
- Waitlist controll
- description
- Participants will get access to the app after three months.
Primary outcomes (1)
- measure
- Change (from baseline) in Prolonged Grief Disorder-13 instrument, PG-13
- timeFrame
- 3, 6 and 12 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Parents/caregivers of children who have died of cancer, at the earliest 12 month ago * Have symptoms of prolonged grief (PGD) * Understand Swedish language * Have access to a smartphone Exclusion Criteria: * Ongoing severe psychiatric problems (e.g. suicidal thoughts, psychosis)
References
Publications (3)
- DERIVEDSveen J, Eisma MC, Boelen PA, Arnberg FK, Eklund R. My grief app for prolonged grief in bereaved parents: a randomised waitlist-controlled trial. Cogn Behav Ther. 2025 Jul;54(4):514-530. doi: 10.1080/16506073.2024.2429068. Epub 2024 Nov 14. PMID 39540459
- DERIVEDEklund R, Eisma MC, Boelen PA, Arnberg FK, Sveen J. My Grief App for Prolonged Grief in Bereaved Parents: A Pilot Study. Front Psychiatry. 2022 Apr 25;13:872314. doi: 10.3389/fpsyt.2022.872314. eCollection 2022. PMID 35546953
- DERIVEDEklund R, Eisma MC, Boelen PA, Arnberg FK, Sveen J. Mobile app for prolonged grief among bereaved parents: study protocol for a randomised controlled trial. BMJ Open. 2021 Dec 7;11(12):e052763. doi: 10.1136/bmjopen-2021-052763. PMID 34876429